Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen lysine salt for acute pain after molar extraction
2019-002114-38Phase 3Terminated
- Sponsor
- Dompé
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alveolar osteitis (AO) comparing Ketoprofen lysine salt with Placebo (2 arms). Primary endpoint: Reduction in pain intensity over 30 minutes. Started Jan 2021; status: terminated.
02
Drugs
ketoprofen lysine salt
03
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on 2019-002114-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002114-38.